MedPath

Provepharm, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

FDA:8

Drug Approvals

Piperacillin and Tazobactam

Approval Date
Feb 26, 2025
FDA

EXTENCILLINE

Approval Date
Mar 25, 2024
FDA

tranexamic acid

Approval Date
Mar 6, 2024
FDA

PIPERACILLIN AND TAZOBACTAM

Approval Date
Feb 14, 2024
FDA

Phenylephrine hydrochloride

Approval Date
Oct 11, 2023
FDA

Dihydroergotamine Mesylate

Approval Date
Oct 11, 2023
FDA

ANTICHOLIUM

Approval Date
Sep 14, 2023
FDA

BLUDIGO

Approval Date
Jan 20, 2023
FDA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy